Skip to content

Pharminent

Primary Menu
  • Home
    • Pro Hub
Light/Dark Button
Hub
  • Home
  • Other
  • 220: An Interview With Dr. Jaime Moore on Obesity Medications and Neuromuscular Disease
  • Other

220: An Interview With Dr. Jaime Moore on Obesity Medications and Neuromuscular Disease

Rare Disease Audio

Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Jaime Moore, MD, about weight loss drugs--specifically the role of GLP-1 receptor agonists in treating children with neuromuscula

OtherMetabolic & GLP-1Read full story

pharminent April 13, 2026 (Last updated: April 13, 2026)

Rare Disease Audio

Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Jaime Moore, MD, about weight loss drugs–specifically the role of GLP-1 receptor agonists in treating children with neuromuscula

OtherMetabolic & GLP-1Read full story

Post navigation

Previous: Revolution rises 40% as pancreatic cancer drug doubles survival
Next: Allogene stock sails after CAR T clears residual lymphoma in early data cut

Related Stories

  • Other

Takeda and Weave Bio collaborate on AI-driven automation in drug development

pharminent September 2, 2026
  • Other

ASCO ’26: Bispecifics vs. ADCs, a ‘RAS’ revolution and a step change in prostate cancer

pharminent June 2, 2026
  • Other

ASCO26: Symptom-tracking app helps advanced cancer patients

pharminent June 2, 2026
  • Home
  • Contact
© 2026 All rights reserved. | ReviewNews by AF themes.